Indication
Bubonic
1 clinical trial
3 products
Clinical trial
An Open-label, Randomised, Non-inferiority Trial of the Efficacy and Safety of Ciprofloxacin Versus an Aminoglycoside Followed by Ciprofloxacin in the Treatment of Bubonic PlagueStatus: Recruiting, Estimated PCD: 2024-04-30
Product
CiprofloxacinProduct
StreptomycinProduct
Gentamicin